Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BA.1.1.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
FL.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
FL.15.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
JD.1.1.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
CM.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.523SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BU.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
CM.7.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
CK.2.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BA.2.31.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BE.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.587SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.333SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
JN.2.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AK.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.79 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.120.2.1 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.365SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.71 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.208SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.125.1 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.78 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.43.5 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
XBC.1.6.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.177.40SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.160.27SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.4.2.4 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.177.75SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.177.35SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.527SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.500SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.177.68SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.88SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
CM.8.1.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BA.5.2.40SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
XBB.2.11.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.15 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.423SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
AY.29 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.318SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.178SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.177.45SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
XDSWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.227SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.385SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.479SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.437SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
B.1.1.327SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used